Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Upper Respiratory Tract Infections Management

Initial Management: Supportive Care First-Line

  • The American Academy of Pediatrics and other medical societies recommend symptomatic treatment, not antibiotics, as the cornerstone of URTI management, with analgesics, antipyretics, saline nasal irrigation, intranasal corticosteroids, and systemic or topical decongestants as needed 2, 3, 4
  • Topical decongestants, such as oxymetazoline, should be used for no more than 3 days to avoid rhinitis medicamentosa (rebound congestion) 4
  • Over-the-counter cough and cold medications should be avoided in children under 6 years due to lack of efficacy and potential toxicity 4

When Antibiotics ARE Indicated

  • Antibiotics are appropriate only in specific circumstances, such as acute bacterial rhinosinusitis, with clinical criteria requiring antibiotics including unilateral or bilateral infraorbital pain, pulsatile pain, failure of initial symptomatic treatment, severe symptoms, and complications 3, 5, 2
  • First-line antibiotic choices for maxillary sinusitis include amoxicillin-clavulanate, cefuroxime-axetil, cefpodoxime-proxetil, or pristinamycin, with a duration of 7-10 days standard 3, 5, 2
  • Cefixime is specifically not recommended for sinusitis due to inactivity against pneumococci with decreased penicillin susceptibility 6

Monitoring and Treatment Failure

  • Reassess after 2-3 days of antibiotic therapy, with primary criterion being fever resolution, and consider hospitalization for complications or underlying diagnoses 2, 7

Common Pitfalls to Avoid

  • Antibiotics should not be prescribed for common cold, influenza, COVID-19, laryngitis, or uncomplicated acute bronchitis, and cefixime should not be used for respiratory infections where pneumococcal coverage is needed 2, 6
  • Antihistamine-decongestant combinations should not be used in young children, and fluoroquinolones should be reserved for complicated sinusitis or first-line treatment failure only 4, 3, 5